OakChart

Accendra Health Inc

ACHHealthcare·Medical Distribution·USA·Nano·NYSE·Nov 12 • 3:59 PM ET

0.15+0.00 (0.69%)
2026-11-13 13:05 CET
Market cap
$11.24M
Revenue, TTM
2,551.76 USD m
Net income, TTM
-171.56 USD m
Free cash flow, TTM
-166.84 USD m
EPS diluted, TTM
-2.24
Price / earnings
-
Compare

Price

ACH against its 20, 50 and 200-day averages
Terms2050200BeatMiss
Patternshover a marker to name it
RS 0Sales 624Price6246380.002.004.0017.2M34.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ACHclose 0.1520-day 0.2250-day 0.54200-day 2.150.1552w high 4.6952-week range, not 6 months

96.9% under the 52-week high of 4.69 on 11 May 2026. 52-week low 0.13 on 11 Nov 2026. Last 15 sessions, 148.1% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 0
CANSLIM 3 of 6 — fails: EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 2 of 4 — fails: EPS Growth This Year: High (>25%); Return on Equity: Over +15%
Quality 0 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Current Ratio: Over 1 — not on the tape: Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: Return on Equity: Over +15% — not on the tape: P/E: Under 15; P/B: Under 2; Debt/Equity: Low (<0.1)
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 2 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200

Profile

ACH
52-week range, 0% of the way up
0.134.69

Accendra Health, Inc. engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Its brands include Apria and Byram Healthcare. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

IndexRUT
Employees6500
IPONov 01, 1982
Beta1.65
ATR, 14d0.05
Rel volume0.00
Short float14.60%
Insider own9.79%
Inst own89.45%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$11.24M
Enterprise Value1.84B
Income-171.56M
Sales2.55B
Book / share-7.39
Cash / share0.35
Dividend Est.-
Dividend TTM-
Dividend Ex-DateJun 30, 2022
Dividend Gr. 3/5Y- -
Payout-
Employees6500
IPONov 01, 1982

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales0.00
Price / book-
Price / cash0.42
Price / free cash flow-
Value / cash profit7.51
Value / sales0.72
Quick Ratio0.29
Current Ratio0.41
Debt / equity-
Long-term debt / equity-
Options and shortYes / Yes

Earnings

Earnings / share-2.24
Earnings next year-0.34
Earnings next quarter0.01
Earnings this year-147.43%
Earnings next year29.69%
Earnings growth, 5 years-
Past earnings growth- -
Past sales growth-34.78% -20.10%
Earnings vs last year87.15%
Sales vs last year-61.96%
Earnings vs last quarter86.83%
Sales vs last quarter-13.69%
EarningsNov 05 AMC
Surprise-3532.84% -2.68%

Ownership

Insiders own9.79%
Insider trades0.00%
Institutions own89.45%
Institution trades16.70%
Return on assets-4.02%
Return on equity-198.35%
Return on capital-14.15%
Gross Margin39.93%
Operating margin0.53%
Profit Margin-6.72%
20-day average-34.14%
50-day average-72.72%
200-day average-93.21%

Technical

Shares out76.92M
Shares floating69.43M
Short / float14.60%
Short ratio4.08
Short interest10.14M
52-week high4.69 -96.9%
52-week low0.13 +9.8%
Volatility22.40% 20.37%
Average range0.05
Strength index23.79
Market sensitivity1.65
Relative volume0.00
Avg Volume2.48M
Volume0

Performance

Perf Week-51.02%
Perf Month-53.32%
Perf Quarter-84.65%
Perf Half Y-95.20%
Perf YTD-94.79%
Perf Year-95.03%
Perf 3Y-99.15%
Perf 5Y-99.66%
Perf 10Y-99.55%
Recommendation3.50
Target Price1.17
Prev Close0.15
Price0.15
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 11, 2026DowngradeRobert W. BairdOutperform → Neutral$1.50+927.4%
Aug 11, 2026DowngradeCitigroupBuy → Neutral$1.50+927.4%
Nov 03, 2025DowngradeUBSBuy → Neutral$4+2,639.7%
Jul 19, 2024UpgradeCitigroupNeutral → Buy$24 → $19+12,913.7%
Feb 26, 2024InitiatedLeerink PartnersMarket Perform$24+16,338.4%
Jan 03, 2024InitiatedBarclaysEqual Weight$21+14,283.6%
Oct 13, 2022DowngradeCitigroupBuy → Neutral$52 → $18+12,228.8%
Oct 12, 2022DowngradeRobert W. BairdOutperform → Neutral$62 → $22+14,968.5%
Oct 12, 2022DowngradeBofA SecuritiesBuy → Underperform$43 → $17+11,543.8%
Apr 26, 2022ResumedCitigroupBuy$55+37,571.2%

Peers

Mkt cap
TickerCompanyMkt cap
AHCOAdaptHealth Corp1.07B
VMDViemed Healthcare Inc348.24M
INGNInogen Inc146.13M
HSICHenry Schein Inc9.52B
RMDResmed Inc33.60B
AVAHAveanna Healthcare Holdings Inc2.67B
OPCHOption Care Health Inc4.75B
ADUSAddus HomeCare Corp2.31B
GRDNGuardian Pharmacy Services Inc3.13B
PNTGPennant Group Inc1.26B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Coliseum Capital Management, L10% StockholderSep 11 '26Proposed Sale1.0810,726,75911,584,900Sep 11 04:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VTWOVanguard Russell 2000 Index ETFAUM: 16.90B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 9.04B
VHTVanguard Health Care ETFAUM: 21.54B
IWNiShares Russell 2000 Value ETFAUM: 14.17B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.56B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.54B

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS -0.230 missed 0.007, from 0.250 a year earlier. Sales 601.78 missed 618.33, from 697.26 a year earlier
EPS
0.5500-0.2302024Q4 EPS 0.550 against 0.52124Q42025Q1 EPS 0.230 against 0.20125Q12025Q2 EPS 0.260 against 0.27525Q22025Q3 EPS 0.250 against 0.23525Q32025Q4 EPS 0.210 against 0.22125Q42026Q1 EPS -0.040 against -0.09826Q12026Q2 EPS -0.190 against -0.08426Q22026Q3 EPS -0.230 against 0.00726Q3
Sales, USD millions
2,73002024Q4 sales 2,696 against 2,68424Q42025Q1 sales 2,632 against 2,66225Q12025Q2 sales 681.9 against 2,73025Q22025Q3 sales 697.26 against 704.4825Q32025Q4 sales 708.97 against 713.4325Q42026Q1 sales 627.8 against 644.1826Q12026Q2 sales 613.2 against 628.6626Q22026Q3 sales 601.78 against 618.3326Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-05 16:30-0.2300.007-0.230601.78618.33EPS -3532.8% · sales -2.7%vs 2025Q3, year-ago quarter · EPS -192.0% · sales -13.7%3 EPS · 4 salesOpen -18.08% vs SPY +0.25%. Close -31.87% vs SPY +0.31%
2026Q2ended 2026-06-302026-08-10 08:30-0.190-0.084-1.161613.2628.66EPS +126.7% · sales -2.5%vs 2025Q2, year-ago quarter · EPS -173.1% · sales -10.1%5Open -37.86% vs SPY -0.09%. Close -50.00% vs SPY -0.03%
2026Q1ended 2026-03-312026-05-11 08:30-0.040-0.098-0.085627.8644.18EPS -59.3% · sales -2.5%vs 2025Q1, year-ago quarter · EPS -117.4% · sales -76.1%5Open +10.75% vs SPY -0.16%. Close +8.66% vs SPY +0.23%
2025Q4ended 2025-12-312026-02-19 16:300.2100.221-0.734708.97713.43EPS -5.1% · sales -0.6%vs 2024Q4, year-ago quarter · EPS -61.8% · sales -73.7%6 EPS · 7 salesOpen -12.10% vs SPY -0.32%. Close +5.24% vs SPY +0.72%
2025Q3ended 2025-09-302025-10-30 16:300.2500.235-1.944697.26704.48EPS +6.4% · sales -1.0%vs 2024Q3, year-ago quarter · EPS -40.5% · sales -74.4%6 EPS · 7 salesOpen +0.40% vs SPY +0.77%. Close -19.96% vs SPY +0.33%
2025Q2ended 2025-06-302025-08-11 08:300.2600.275-11.296681.92,730EPS -5.5% · sales -75.0%vs 2024Q2, year-ago quarter · EPS -27.8% · sales -74.5%6 EPS · 7 salesOpen -16.50% vs SPY +0.04%. Close -34.70% vs SPY -0.20%
2025Q1ended 2025-03-312025-05-08 08:300.2300.201-0.3232,6322,662EPS +14.4% · sales -1.1%vs 2024Q1, year-ago quarter · EPS +21.1% · sales +0.7%6Open +7.47% vs SPY +0.73%. Close -9.92% vs SPY +0.70%
2024Q4ended 2024-12-312025-02-28 08:300.5500.521-3.8372,6962,684EPS +5.7% · sales +0.4%vs 2023Q4, year-ago quarter · EPS -20.3% · sales +1.5%6Open +12.34% vs SPY +0.09%. Close +39.04% vs SPY +1.56%
2024Q3ended 2024-09-302024-11-04 08:300.4200.414-0.1662,7212,681EPS +1.4% · sales +1.5%vs 2023Q3, year-ago quarter · EPS -4.5% · sales +5.0%7 EPS · 6 salesOpen -4.64% vs SPY +0.02%. Close -10.18% vs SPY -0.22%
2024Q2ended 2024-06-302024-08-02 08:300.3600.330-0.4162,6712,646EPS +9.0% · sales +0.9%vs 2023Q2, year-ago quarter · EPS +100.0% · sales +4.2%7 EPS · 6 salesOpen -5.91% vs SPY -1.34%. Close -1.34% vs SPY -1.86%
2024Q1ended 2024-03-312024-05-03 08:300.1900.179-0.2872,6132,610EPS +6.1% · sales +0.1%vs 2023Q1, year-ago quarter · EPS +280.0% · sales +3.6%7 EPS · 6 salesOpen -2.65% vs SPY +1.21%. Close -25.70% vs SPY +1.24%
2023Q4ended 2023-12-312024-02-20 08:300.6900.6630.2292,6562,669EPS +4.0% · sales -0.5%vs 2022Q4, year-ago quarter · EPS +146.4% · sales +4.1%6 EPS · 5 salesOpen +3.72% vs SPY -0.36%. Close +1.56% vs SPY -0.55%
2023Q3ended 2023-09-302023-11-03 08:300.4400.375-0.0842,5922,578EPS +17.3% · sales +0.5%vs 2022Q3, year-ago quarter · EPS +7.3% · sales +3.8%5 EPS · 4 sales-
2023Q2ended 2023-06-302023-08-04 08:300.1800.177-0.3732,5632,491EPS +1.5% · sales +2.9%vs 2022Q2, year-ago quarter · EPS -76.3% · sales +2.5%6 EPS · 5 sales-
2023Q1ended 2023-03-312023-05-05 08:300.050-0.092-0.3252,5232,404EPS -154.3% · sales +5.0%vs 2022Q1, year-ago quarter · EPS -94.8% · sales +4.8%5-
2022Q4ended 2022-12-312023-02-28 08:300.2800.401-0.7732,5512,461EPS -30.2% · sales +3.7%vs 2021Q4, year-ago quarter · EPS -65.4% · sales +3.4%6 EPS · 5 sales-

Annual earnings

2025FY EPS 1.010 missed 1.014, from 1.530 a year earlier. Sales 2,762 missed 2,767, from 10,701 a year earlier
EPS
4.10002018FY EPS 1.150 against 1.21420182019FY EPS 0.600 against 0.55320192020FY EPS 2.260 against 1.93920202021FY EPS 4.100 against 4.01620212022FY EPS 2.420 against 2.53220222023FY EPS 1.360 against 1.34420232024FY EPS 1.530 against 1.49620242025FY EPS 1.010 against 1.0142025
Sales, USD millions
10,70102018FY sales 9,839 against 9,74720182019FY sales 9,211 against 9,83120192020FY sales 8,480 against 8,28220202021FY sales 9,785 against 9,75220212022FY sales 9,955 against 9,87420222023FY sales 10,334 against 10,34720232024FY sales 10,701 against 10,68920242025FY sales 2,762 against 2,7672025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate--0.080----
2029FYestimate-0.030--2,8594.87
2028FYestimate--0.199--2,659-
2027FYestimate--0.337--2,548-
2026FYestimate--0.479--2,475-
2025FY1.0101.014-14.3102,7622,7672.77
2024FY1.5301.496-4.72610,70110,6898.54
2023FY1.3601.344-0.54510,33410,34714.17
2022FY2.4202.5320.2949,9559,8748.07
2021FY4.1004.0162.9369,7859,75210.61
2020FY2.2601.9390.4708,4808,28211.97
2019FY0.6000.553-1.0309,2119,8318.62
2018FY1.1501.214-7.2829,8399,7475.50
2017FY1.6101.6461.2009,3189,31911.73
2016FY2.0502.0401.7609,7239,76117.22
2015FY2.0001.9311.6509,7739,7980.07
2014FY1.7601.7631.0609,4409,3980.08
2013FY1.9001.8861.7609,0729,1790.08
2012FY1.8501.9071.7208,9088,8610.08
2011FY1.9401.9041.8108,6288,6160.08
2010FY1.9401.9201.7508,1248,1110.08

Quarterly results

2026Q3 revenue 601.77, from 697.26 a year earlier. Operating margin 1.1%, from 4.2% a year earlier
Revenue, USD millions
2,69602024Q4 revenue 2,69624Q42025Q1 revenue 2,63225Q12025Q2 revenue 681.9225Q22025Q3 revenue 697.2625Q32025Q4 revenue 708.9725Q42026Q1 revenue 627.7826Q12026Q2 revenue 613.2326Q22026Q3 revenue 601.7726Q3
Operating margin
7.20-1.52024Q4 operating margin 2.7%24Q42025Q1 operating margin 1.9%25Q12025Q2 operating margin 7.2%25Q22025Q3 operating margin 4.2%25Q32025Q4 operating margin 3.1%25Q42026Q1 operating margin -1.0%26Q12026Q2 operating margin -1.5%26Q22026Q3 operating margin 1.1%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E -0.48 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-11-0.48-0.2%
2026Q4Eper share2026-11-110.01+4.4%
2026Q4Rper share2026-11-11-0.14-0.4%
2026FYSUSD millions2026-11-102,475-0.3%
2026Q4S-2026-11-10623.77-0.4%
2026FYRper share2026-11-06-1.89+17.1%
2026Q3Rper share2026-10-26-0.260.0%
2026Q3S-2026-10-26618.330.0%
2026Q3Eper share2026-10-250.010.0%
2026Q2Eper share2026-07-25-0.080.0%
2026Q2Rper share2026-07-25-0.300.0%
2026Q2S-2026-07-25628.660.0%
2026Q1Eper share2026-05-09-0.100.0%
2026Q1Rper share2026-05-09-0.280.0%
2026Q1S-2026-05-06644.180.0%
2025Q4Eper share2026-01-240.220.0%
2025Q4Rper share2026-01-24-0.040.0%
2025FYEper share2026-01-141.010.0%
2025FYRper share2026-01-14-1.430.0%
2025Q4S-2026-01-14713.430.0%
2025FYSUSD millions2026-01-092,7670.0%
2025Q3Eper share2025-10-250.240.0%
2025Q3Rper share2025-10-250.050.0%
2025Q3S-2025-10-25704.480.0%
2025Q2Eper share2025-08-040.280.0%
2025Q2Rper share2025-08-04-0.300.0%
2025Q2SUSD millions2025-06-052,730-0.1%
2025Q1SUSD millions2025-04-192,6620.0%
2025Q1Eper share2025-04-170.200.0%
2025Q1Rper share2025-04-16-0.06+31.1%
2024FYEper share2025-02-121.50-0.9%
2024Q4Eper share2025-02-120.52-2.5%
2024FYSUSD millions2025-02-1210,6890.0%
2024Q4SUSD millions2025-02-122,684-0.1%
2024FYRper share2025-02-03-3.26+229.3%
2024Q4Rper share2025-02-03-2.16-2003.5%
2024Q3Eper share2024-11-030.410.0%
2024Q3SUSD millions2024-11-032,6810.0%
2024Q3Rper share2024-10-160.000.0%
2024Q2Eper share2024-07-300.330.0%
2024Q2Rper share2024-07-26-0.17+257.0%
2024Q2SUSD millions2024-07-262,646+0.1%
2024Q1Eper share2024-03-310.180.0%
2024Q1Rper share2024-03-31-0.200.0%
2024Q1SUSD millions2024-02-292,610+0.0%
2023FYEper share2024-01-301.340.0%
2023FYRper share2024-01-301.330.0%
2023FYSUSD millions2024-01-2610,3470.0%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share1.2-7.282-1.030.472.9360.294-0.545-4.726-14.313-2.2365-
Sales USD millions9,3229,4189,2118,4809,7859,95510,3342,6802,7622,552-
Shares million shares616263737576777776-77
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share-0.166-3.837-0.323-11.296-1.944-0.734-0.085-1.161-0.256
Sales USD millions2,7212,6962,632682697709628613602
Shares million shares777777777776777777

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue2,551.762,762.03+3.1%2,680.11-74.1%10,333.97+3.8%9,955.48+1.7%9,785.32+15.4%8,480.18-7.9%9,210.94-2.2%9,418.19
Cost of Goods Sold Incl. D&A1,532.921,560.43+7.3%1,454.22-82.9%8,496.18+1.7%8,357.79-0.1%8,362.71+14.7%7,292.68-10.8%8,179.71-3.0%8,431.07
Gross Profit1,018.831,201.61-2.0%1,225.89-33.3%1,837.78+15.0%1,597.68+12.3%1,422.61+19.8%1,187.50+15.2%1,031.23+4.5%987.13
Selling, General and Administrative Excl. Other1,005.581,053.87-1.3%1,067.86-34.4%1,627.22+15.8%1,405.00+36.9%1,026.25+8.3%948.00+2.3%926.32+6.5%869.47
Other Operating Expense-0.33-2.42-17.120.000.000.000.000.000.00
Operating Income13.58150.16-14.3%175.16-16.8%210.57+9.3%192.68-51.4%396.36+65.5%239.50+128.3%104.91-10.8%117.66
Interest Expense134.52129.20+12.0%115.39-31.2%167.63+30.7%128.24+166.7%48.09-35.2%74.17-22.5%95.69+34.8%70.98
Unusual Expense26.66122.70-68.8%392.88+310.9%95.61+73.8%55.02+12.3%48.99+29.8%37.75+22.4%30.85-93.5%473.05
Net Income Before Taxes-148.66-101.95-329.88-54.73-602.6%10.89-96.1%276.75+151.8%109.91-28.72-427.09
Income Taxes-25.720.73-96.5%20.85-13.43-11.50-120.8%55.16+152.7%21.83-6.13-32.43
Consolidated Net Income-122.94-102.68-350.74-41.30-284.5%22.39-89.9%221.59+151.6%88.07-22.58-394.67
Net Income From Continuing Operations-122.94-102.68-350.74-41.30-284.5%22.39-89.9%221.59+151.6%88.07-22.58-394.67
Net Income-171.56-1,100.64-362.69-41.30-284.5%22.39-89.9%221.59+641.8%29.87-62.37-437.01
EPS (Recurring) per share-1.99-13.20-1.14-435.3%0.34-57.5%0.80-76.4%3.39+280.9%0.89-0.67-1.76
EPS (Basic, Before Extraordinaries) per share-2.24-14.31-4.73-0.55-283.3%0.30-90.2%3.05+548.9%0.47-1.03-7.28
EPS (Diluted) per share-2.24-14.31-4.73-0.55-289.7%0.29-90.1%2.94+525.5%0.47-1.03-7.28
EBITDA244.47364.68+2.3%356.44-28.4%497.94+18.2%421.35-13.5%486.98+46.3%332.83+65.0%201.66+0.3%201.06
Non-Operating Income (Expense)-1.07-0.21-106.5%3.24-2.05-239.5%1.47-22.52-17.67-7.09-0.73
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense13.5113.00-23.5%17.00+25.1%13.59-12.3%15.50-16.2%18.50+26.7%14.60+30.4%11.20-5.9%11.90
Price To Earnings Ratio ratio statement ratio, not the snapshot----12.1514.5870.61--
Price To Sales Ratio ratio0.020.080.370.140.150.340.200.030.04
Gross Margin %39.9343.5045.7417.7816.0514.5414.0011.2010.48
Operating Margin %0.535.446.542.041.944.052.821.141.25
Net Margin %-6.72-39.85-13.53-0.400.222.260.35-0.68-4.64
Shares Outstanding million shares76.9276.39-1.0%77.20+0.8%76.55+0.4%76.28+1.1%75.43+2.7%73.47+16.9%62.84+0.9%62.29
Market Capitalization11.2411.24-98.9%1,007.81-31.6%1,474.17-1.0%1,488.86-54.6%3,282.33+65.1%1,988.51+512.0%324.94-17.6%394.16

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue601.77-13.7%613.23-10.1%627.78-76.1%708.97-73.7%697.26-74.4%681.92-74.5%2,632.05+0.7%2,696.07+1.5%
Cost of Goods Sold Incl. D&A349.11-14.3%382.53-0.6%382.61-82.3%418.68-80.8%407.47-81.7%384.83-82.4%2,167.19+0.7%2,181.49+1.1%
Gross Profit252.66-12.8%230.70-22.3%245.18-47.3%290.29-43.6%289.79-41.8%297.09-38.1%464.86+0.7%514.58+3.1%
Selling, General and Administrative Excl. Other245.82-6.3%239.85-3.3%251.37-39.4%268.53-39.2%262.43-37.9%247.94-41.2%414.98-2.1%441.68+7.0%
Other Operating Expense0.000.00-0.06-0.26-1.76-0.12-0.27-0.46
Operating Income6.84-76.5%-9.15-118.6%-6.13-112.2%22.02-70.0%29.12-65.9%49.27-24.5%50.15+33.3%73.36-15.0%
Interest Expense38.03+26.9%34.95-22.7%32.87-6.3%28.67-23.0%29.98-21.7%45.23+19.8%35.07-8.4%37.24-5.7%
Unusual Expense5.51+107.9%43.29-77.8%-23.26-149.1%1.11-99.7%2.65-94.2%195.37+392.6%47.38+73.1%344.34+1268.1%
Net Income Before Taxes-36.82-87.63-16.25-7.97-3.63-84.95-35.07-299.65-1526.9%
Income Taxes-18.86-1057.4%1.44-9.781.471.97-1.13-107.5%-10.09-3.54-210.3%
Consolidated Net Income-17.96-89.07-6.47-9.44-5.61-83.82-24.98-296.12-1765.5%
Net Income From Continuing Operations-17.96-89.07-6.47-9.44-5.61-83.82-24.98-296.12-1765.5%
Net Income-19.70-89.07-6.47-56.33-150.28-869.06-24.98-296.12-1765.5%
EPS (Recurring) per share-0.21-0.77-0.30-372.7%-0.72-1.92-868.0%-9.520.11-0.71-254.3%
EPS (Basic, Before Extraordinaries) per share-0.26-1.16-0.08-0.73-1.94-11.30-0.32-3.84-1769.6%
EPS (Diluted) per share-0.26-1.16-0.08-0.73-1.94-11.30-0.32-3.84-1769.6%
EBITDA45.76-50.9%56.55-48.0%55.61-50.0%86.56-37.5%93.22-36.5%108.67-15.8%111.30-0.4%138.54-11.8%
Non-Operating Income (Expense)-0.12-0.23-100.2%-0.50-0.21-102.5%-0.13106.38-2.77-394.7%8.57
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.10+34.6%3.16-51.4%2.05-65.7%6.20-38.3%1.56-62.9%6.50+169.7%5.97+79.8%10.05+3.2%
Price To Sales Ratio ratio0.020.100.060.050.060.080.070.09
Gross Margin %41.9937.6239.0540.9541.5643.5717.6619.09
Operating Margin %1.14-1.49-0.983.114.187.231.912.72
Net Margin %-3.27-14.52-1.03-7.94-21.55-127.44-0.95-10.98
Shares Outstanding million shares76.92-0.5%76.91-0.4%76.58-0.8%76.39-1.0%77.30+0.3%77.20+0.2%77.22+1.0%77.20+0.8%
Market Capitalization11.24-97.0%261.92-62.4%174.28-75.0%216.57-78.5%370.77-69.3%697.19-32.5%697.54-67.1%1,007.81-31.6%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments281.99+922.8%27.57-89.9%272.92+292.9%69.47+24.7%55.71-52.9%118.18+76.3%67.03+1.1%66.31-36.6%104.52
Short Term Receivables95.91-56.1%218.27-63.5%598.26-21.6%763.50+12.0%681.56-2.7%700.79+3.9%674.71-10.8%756.69-20.4%951.04
Inventories74.44+10.2%67.58-93.9%1,110.61-16.7%1,333.59-10.9%1,495.97+21.3%1,233.75+7.6%1,146.19-10.0%1,273.73+28.6%990.19
Other Current Assets95.54-94.4%1,707.59+1311.2%121.00-5.9%128.64+45.3%88.56+6.5%83.14-84.0%519.36+17.5%441.86+224.5%136.15
Total Current Assets547.87-72.9%2,021.02-3.9%2,102.79-8.4%2,295.18-1.1%2,321.81+8.7%2,135.86-11.3%2,407.28-5.2%2,538.58+16.3%2,181.91
Net Property, Plant & Equipment365.26-2.9%376.21-55.2%840.50-2.1%858.93+68.0%511.24+11.0%460.42+0.6%457.65+41.3%323.94+56.9%206.49
Total Investments and Advances1.34-78.1%6.11-27.7%8.45-49.5%16.72+2.5%16.320.0%16.32+0.4%16.260.000.00
Intangible Assets1,364.61-5.1%1,438.20-28.1%2,000.68-3.9%2,081.75+228.4%633.93-6.1%675.44-6.4%721.80-6.9%775.20-19.3%960.08
Other Assets172.69-78.8%814.62+478.2%140.90+5.4%133.70+151.1%53.24+11.8%47.60+18.7%40.09-70.5%136.07+389.1%27.82
Total Assets2,451.76-47.3%4,656.16-8.6%5,093.32-5.4%5,386.28+52.3%3,536.55+6.0%3,335.64-8.4%3,643.08-3.5%3,773.79+11.8%3,376.29
Short Term Debt Incl. Current Port. of LT Debt293.27+248.8%84.08-71.5%295.39+272.3%79.34+80.9%43.85+27.1%34.50+5.9%32.580.000.00
Accounts Payable363.56+1.0%359.93-69.3%1,171.88+2.1%1,147.41+14.5%1,001.96+0.2%1,000.19+23.8%808.03-24.1%1,065.20-0.7%1,072.47
Other Current Liabilities290.24-79.4%1,408.04+231.6%424.61+25.0%339.72+13.9%298.21-4.1%311.04-46.0%575.54+41.5%406.81+71.5%237.26
Total Current Liabilities947.08-48.9%1,852.05-2.1%1,891.88+20.8%1,566.47+16.6%1,344.02-0.1%1,345.73-5.0%1,416.16-3.8%1,472.01+12.4%1,309.73
Long Term Debt1,870.19-0.9%1,887.86-10.7%2,113.03-21.7%2,698.44+143.2%1,109.78+0.3%1,105.95-32.0%1,625.49-1.4%1,647.92+83.0%900.74
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-19.44-53.3%41.65-31.5%60.83+72.3%35.31-30.3%50.64+24.9%40.55-20.3%50.85-31.5%74.25
Other Liabilities95.47-69.2%310.44+153.2%122.59+6.7%114.94+5.5%108.94-10.2%121.27+22.8%98.73+16.7%84.59+11.2%76.09
Total Liabilities2,912.74-28.4%4,069.79-2.4%4,169.16-6.1%4,440.68+70.9%2,598.05-1.0%2,623.59-17.5%3,180.93-2.3%3,255.37+37.9%2,360.81
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-460.98-178.6%586.36-36.6%924.17-2.3%945.60+0.8%938.50+31.8%712.05+54.1%462.15-10.9%518.42-48.9%1,015.48
Total Shareholders Equity-460.98-178.6%586.36-36.6%924.17-2.3%945.60+0.8%938.50+31.8%712.05+54.1%462.15-10.9%518.42-48.9%1,015.48
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity-460.98-178.6%586.36-36.6%924.17-2.3%945.60+0.8%938.50+31.8%712.05+54.1%462.15-10.9%518.42-48.9%1,015.48
Total Liabilities & Stockholders Equity2,451.76-47.3%4,656.16-8.6%5,093.32-5.4%5,386.28+52.3%3,536.55+6.0%3,335.64-8.4%3,643.08-3.5%3,773.79+11.8%3,376.29
Book Value Per Share per share-6.03-179.3%7.60-37.0%12.07-2.7%12.40-0.3%12.44+28.4%9.69+31.8%7.35-11.7%8.32-49.6%16.52
Tangible Book Value Per Share per share-23.90-11.03-14.06-14.89-468.6%4.04+708.0%0.50-4.13-4.12-557.8%0.90
Full-Time Employees people6,500-72.0%23,200+4.5%22,200-1.3%22,500+30.1%17,300-8.0%18,800+22.1%15,400-14.0%17,900+108.1%8,600
Price to Book Ratio ratio-0.021.151.661.543.502.790.700.761.15
Return on Assets %-2.89-7.19-0.790.506.452.52-0.61-11.042.35
Return on Equity %-197.00-46.44-4.422.3826.8515.00-4.61-51.467.26
Return on Invested Capital %-78.10-14.66-1.360.6110.821.64-2.99-20.173.74
Quick Ratio ratio0.501.050.520.610.610.670.890.860.91
Current Ratio ratio0.581.091.111.471.731.591.701.721.67

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income-173.30-1,100.64-362.69-41.30-284.5%22.39-89.9%221.59+641.8%29.87-62.37-437.01
Depreciation196.23214.52+18.3%181.28-36.9%287.38+25.7%228.67+152.3%90.62-2.9%93.34-20.0%116.68+14.5%101.93
Other Funds (Non Cash)-236.09728.01+127.0%320.73-16.64-1.60-101.8%88.07-5.8%93.45+65.3%56.52-87.9%465.42
Funds from Operations-228.07-176.00-234.1%131.28-36.2%205.78-7.8%223.10-39.8%370.54+59.6%232.23+148.6%93.42-2.0%95.32
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital202.7674.21+145.6%30.21-94.4%534.92+424.9%101.91-246.37-355.0%96.63+41.4%68.35+237.2%20.27
Cash from Operating Activities-25.31-101.79-163.0%161.50-78.2%740.71+127.9%325.01+161.7%124.18-62.2%328.86+103.3%161.77+40.0%115.59
Capital Expenditures-140.50-201.32-182.66-207.89-166.58-49.69-59.19-52.23-65.69
Net Assets From Acquisitions-18.09-18.090.000.00-1,684.610.000.000.00-751.83
Sale of Fixed Assets and Businesses524.51420.32+501.1%69.93-2.3%71.57+47.9%48.380.00-100.0%133.23+40272.7%0.33-80.5%1.69
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-54.57-56.48-18.50-0.94-1.67-3.940.000.000.00
Other Sources2.100.00-100.0%14.700.000.000.00-100.0%6.030.000.00
Cash from Investing Activities313.45144.42-116.53-137.25-1,804.48-53.63-167.0%80.07-51.90-815.83
Cash Dividends Paid0.000.000.000.000.00-0.73-0.65-5.23-48.20
Change in Capital Stock-3.52-10.180.000.000.000.00-100.0%189.970.000.00
Repurchase of Common Pref Stock-3.52-10.180.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00-100.0%189.970.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00-100.0%189.970.000.00
Issuance or Reduction of Debt, Net-256.88203.50-244.20-416.69-127.1%1,539.90-95.35-541.85-117.79-115.6%756.49
Change in Long Term Debt-256.88203.50-244.20-416.69-127.1%1,539.90-95.35-541.85-117.79-115.6%756.49
Issuance of Long Term Debt2,386.032,914.78+38.7%2,101.60+341.5%476.00-82.4%2,700.70+381.4%560.99+261.7%155.100.00-100.0%772.74
Reduction of Long Term Debt-2,642.91-2,711.28-2,345.80-892.69-1,160.80-656.34-696.95-117.79-16.25
Net Financing Active Other Cash Flow-47.38-5.24-23.41-0.64-42.79-33.40-16.49-2.87-7.22
Other Financing Activities Uses-5.85-5.24-23.41-0.64-42.79-33.40-16.49-2.87-7.22
Cash from Financing Activities-307.79188.08-267.60-417.33-127.9%1,497.11-129.48-369.02-125.88-118.0%701.07
Exchange Rate Effect0.091.90-0.90-247.5%0.61-3.48-3.54-135.7%9.91-2.67-1.99
Net Change in Cash-19.56232.61-223.54-219.7%186.74+1219.7%14.15-62.47-225.4%49.82-18.68-1.16
Free Cash Flow-166.84-292.75-8.79-101.6%549.84+229.4%166.92+100.6%83.19-70.1%278.43+83.2%151.96+60.3%94.78
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio---2.668.9239.826.182.138.16
Deferred Taxes & Investment Tax Credit--17.89-8.04-23.65-26.36-29.74-291.1%15.56-17.40-35.02

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments26.61-19.0%7.65-80.0%336.88+466.8%281.99+471.1%32.84-44.0%38.26-85.1%59.44-78.0%49.38-81.9%
Short Term Receivables107.32-47.1%120.08-38.9%103.70-82.1%95.91-86.1%202.73-69.4%196.38-70.4%580.17-13.4%692.14+15.7%
Inventories82.10+28.6%73.34+5.9%65.28-95.4%74.44-93.4%63.85-94.9%69.23-94.4%1,408.54+23.1%1,131.88+1.9%
Other Current Assets57.89-96.8%70.37-96.5%82.63-47.7%95.54-35.3%1,832.26+1106.7%1,994.65+1044.8%158.05+4.6%147.62+22.0%
Total Current Assets273.92-87.1%271.45-88.2%588.50-73.3%547.87-72.9%2,131.67+0.7%2,298.51-1.2%2,206.20-1.3%2,021.02-3.9%
Net Property, Plant & Equipment310.61-18.0%305.67-19.5%329.70-63.5%365.26-57.8%378.82-55.7%379.49-56.0%903.44+6.1%864.97+2.9%
Total Investments and Advances0.00-100.0%0.00-100.0%0.00-100.0%1.34-78.1%2.00-89.9%2.75-89.6%3.93-62.1%6.11-27.7%
Intangible Assets1,301.17-7.6%1,306.15-9.3%1,335.38-17.4%1,364.61-18.3%1,408.83-28.0%1,440.06-26.6%1,617.02-18.2%1,671.01-16.5%
Other Assets193.21+68.2%224.14+564.5%162.41+29.1%172.69+85.6%114.90-13.9%33.73-73.7%125.84-4.6%93.05-34.0%
Total Assets2,078.91-48.5%2,107.41-49.3%2,415.98-50.3%2,451.76-47.3%4,036.23-20.6%4,154.55-21.7%4,856.42-6.8%4,656.16-8.6%
Short Term Debt Incl. Current Port. of LT Debt70.99-78.2%38.40-91.0%581.25+1063.7%293.27+114.4%326.03+664.8%426.70+97.2%49.95-76.5%136.77-53.7%
Accounts Payable381.88+12.4%352.80-1.2%374.82-72.9%363.56-71.0%339.73-74.6%357.04-74.2%1,380.74+13.3%1,251.96+6.8%
Other Current Liabilities218.62-87.9%275.02-85.5%247.03-53.3%290.24-40.2%1,800.21+225.2%1,890.78+254.8%529.53+5.6%485.00+14.2%
Total Current Liabilities671.50-72.8%666.22-75.1%1,203.10-38.6%947.08-49.5%2,465.97+27.5%2,674.52+25.5%1,960.21+1.4%1,873.74-1.0%
Long Term Debt1,780.50-7.1%1,781.30+6.3%1,589.41-28.5%1,870.19-10.7%1,916.61-10.0%1,675.73-22.8%2,221.550.0%2,094.26-0.9%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities-----0.34-98.8%16.31-52.6%22.46-46.1%
Other Liabilities195.15+134.7%210.84+148.2%88.24+1.0%95.47-5.0%83.15-28.6%84.96-25.3%87.38-29.1%100.48-18.0%
Total Liabilities2,647.14-40.7%2,658.35-40.1%2,880.75-32.8%2,912.74-28.8%4,465.73+6.2%4,435.56-0.2%4,285.44-0.6%4,090.93-1.9%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity-568.23-550.94-464.76-181.4%-460.98-181.6%-429.51-149.1%-281.01-132.6%570.98-36.2%565.23-38.8%
Total Shareholders Equity-568.23-550.94-464.76-181.4%-460.98-181.6%-429.51-149.1%-281.01-132.6%570.98-36.2%565.23-38.8%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity-568.23-550.94-464.76-181.4%-460.98-181.6%-429.51-149.1%-281.01-132.6%570.98-36.2%565.23-38.8%
Total Liabilities & Stockholders Equity2,078.91-48.5%2,107.41-49.3%2,415.98-50.3%2,451.76-47.3%4,036.23-20.6%4,154.55-21.7%4,856.42-6.8%4,656.16-8.6%
Book Value Per Share per share-7.39-7.16-6.07-182.1%-6.03-182.4%-5.56-149.0%-3.64-132.6%7.39-36.9%7.32-39.4%
Tangible Book Value Per Share per share-24.30-24.15-23.51-23.90-23.78-22.29-13.55-14.32
Full-Time Employees people---6,500-72.0%---23,200+4.5%
Price to Book Ratio ratio-0.02-0.56-0.38-0.50-1.321.231.231.15
Return on Assets %-4.02-3.53-2.90-3.48-9.01-8.83-7.27-7.44
Return on Equity %---198.35-237.61-184.47-144.11-49.91-48.70
Return on Invested Capital %-1.62-7.24-0.58-4.00-10.11-62.31-0.89-11.13
Quick Ratio ratio0.290.300.430.500.840.830.410.47
Current Ratio ratio0.410.410.490.580.860.861.131.08

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income-21.44-89.07-6.47-56.33-150.28-869.06-24.98-296.12-1765.5%
Depreciation38.92-39.3%65.70+10.6%61.74+1.0%29.87-54.2%64.10+4.0%59.40-7.0%61.15-17.5%65.19-7.8%
Other Funds (Non Cash)-33.32-132.2%0.75-99.9%-52.30-426.3%-151.22-148.3%103.62759.5816.03313.06
Funds from Operations-21.14-70.685.55-87.9%-141.79-299.3%-24.02-159.4%-56.15-335.5%45.96+11.8%71.14-11.0%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital3.7344.68-52.3%-55.62209.98-148.5093.76+1.6%-81.02-0.13-100.4%
Cash from Operating Activities-17.41-26.01-169.2%-50.0868.19-4.0%-172.52-731.7%37.61-67.6%-35.0771.00-36.5%
Capital Expenditures-40.08-48.65-42.49-9.29-57.83-69.54-64.67-71.44
Net Assets From Acquisitions0.000.000.00-18.090.000.000.000.00
Sale of Fixed Assets and Businesses45.84+149.7%15.30-15.6%96.42+471.2%366.95+1865.5%18.36+3.6%18.12+3.6%16.88-65.9%18.67+4.1%
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.00-54.570.00-100.0%-1.50-0.410.00
Other Sources0.002.100.000.00-100.0%0.00-100.0%0.000.000.47
Cash from Investing Activities5.77-31.2553.92285.00-39.46-52.92-48.20-52.30
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.00-3.520.00-5.15-1.500.00
Repurchase of Common Pref Stock0.000.000.00-3.520.00-5.15-1.500.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net30.61-77.4%-271.79-824.8%51.50-47.2%-67.20135.7037.5097.50+59.6%-32.75
Change in Long Term Debt30.61-77.4%-271.79-824.8%51.50-47.2%-67.20135.7037.5097.50+59.6%-32.75
Issuance of Long Term Debt144.61-82.2%1,500.02+75.8%269.10-65.4%472.30-42.1%812.30+31.2%853.20+84.6%776.98+279.0%815.20
Reduction of Long Term Debt-114.00-1,771.82-217.60-539.50-676.60-815.70-679.48-847.95
Net Financing Active Other Cash Flow-0.01-100.0%-0.19-0.42-46.7745.40-0.65-3.22-10.35
Other Financing Activities Uses-0.01-100.3%-0.19-0.42-5.243.87-0.65-3.22-10.35
Cash from Financing Activities30.60-83.1%-271.98-958.0%51.08-44.9%-117.50181.1031.7092.78+74.0%-43.10
Exchange Rate Effect0.000.00-100.0%-0.04-107.4%0.13-0.03-102.8%1.260.54-1.31-215.9%
Net Change in Cash18.96-329.23-1965.3%54.89+446.2%235.82-30.9217.65+561.0%10.05-25.71-213.0%
Free Cash Flow-56.58-73.59-91.7255.05+573.8%-226.77-30.27-142.2%-90.768.17-86.7%

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Diabetes Product777.48783.37+0.8%28.4%
Home Respiratory Therapy Product435.95433.05-0.7%15.7%
Ostomy195.92212.84+8.6%7.7%
Product and Service, Other268.27288.19+7.4%10.4%
Sleep Therapy Product702.95740.05+5.3%26.8%
Urology107.12116.02+8.3%4.2%
Wound Care192.41188.51-2.0%6.8%
Total2,680.112,762.03+3.1%100.0%
Region
Name20242025vs 20242025 share
United States2,680.112,762.03+3.1%100.0%
Total2,680.112,762.03+3.1%100.0%
Segment
Name20242025vs 20242025 share
Patient Direct2,680.11---
Total Wholesale-Medical, Dental & Hospital Equipment & Supplies revenue-2,762.03-100.0%
Total2,680.112,762.03+3.1%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3014.60%10.1M69.4M1.87M
2026-10-1513.13%9.1M69.4M1.51M
2026-09-3012.09%8.4M69.7M1.31M
2026-09-1512.77%8.9M69.7M1.17M
2026-08-3112.68%8.8M69.7M1.14M
2026-08-149.27%6.5M69.6M949.08K
2026-07-317.68%5.3M69.3M738.72K
2026-07-158.03%5.6M69.3M796.56K
2026-06-308.45%5.9M69.3M820.48K
2026-06-159.58%6.6M69.3M830.41K
2026-05-298.75%6.1M69.3M841.63K
2026-05-158.43%5.8M69.3M885.79K
2026-04-308.59%5.9M69.3M861.43K
2026-04-159.90%6.9M69.3M948.56K
2026-03-3110.25%7.5M73.6M1.19M
2026-03-1311.14%8.2M73.6M1.39M
2026-02-2711.09%8.2M73.6M1.57M
2026-02-1311.28%8.3M73.6M1.67M
2026-01-3011.86%8.8M74.4M1.98M
2026-01-1512.47%9.3M74.4M2.00M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.050.0410.5481670.000.534-0.0060.000
call1.000.000.050.3512.61820.000.000.505-0.0070.000
call1.500.000.050.0513.6991.000.000.493-0.0070.000
call2.000.000.050.0014.4220.000.000.486-0.0080.000
call2.500.000.450.0015.8610.000.000.481-0.0090.000
call5.000.000.750.0017.5310.000.000.468-0.0100.000
call7.500.000.750.0018.4450.000.000.462-0.0100.000
put0.500.150.400.4011.23132.000.00-0.466-0.0060.000
put1.000.800.900.9012.86511.000.00-0.474-0.0070.000
put1.501.301.451.4020.67114.000.00-0.485-0.0080.000
put2.001.801.901.9014.86010.000.00-0.492-0.0080.000
put2.502.302.452.4022.08619.000.00-0.497-0.0080.000
put5.004.804.904.9017.40210.000.00-0.509-0.0090.000
put7.507.307.407.4019.19114.000.00-0.538-0.0090.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-12SCHEDULE 13GSEC
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-043Initial statement of beneficial ownership of securities2026-10-28SEC
2026-11-038-KCurrent report2026-10-29SEC
2026-11-028-KCurrent report2026-10-29SEC
2026-10-308-KCurrent report2026-10-27SEC
2026-10-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-12-01SEC
2026-10-19PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-19SEC
2026-10-098-KCurrent report2026-10-06SEC
2026-10-07SCHEDULE 13GSEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-09-288-K/A2026-09-16SEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-178-KCurrent report2026-09-16SEC
2026-09-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-178-KCurrent report2026-08-17SEC
2026-08-108-A12BSEC
2026-08-108-KCurrent report2026-08-09SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-07-24EFFECTEffectiveness filing by commission orderSEC
2026-07-15S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-06-258-KCurrent report2026-06-23SEC
2026-06-158-KCurrent report2026-06-09SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-228-KCurrent report2026-05-22SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-194Statement of changes in beneficial ownership of securities2026-05-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Coliseum Capital Management, LLC17.11%
BlackRock, Inc.7.19%
BANK OF AMERICA CORP /DE/4.93%
VANGUARD CAPITAL MANAGEMENT LLC4.03%
D. E. Shaw & Co., Inc.4.02%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC3.77%
Invenomic Capital Management LP3.67%
MARSHALL WACE, LLP3.37%
PARADIGM CAPITAL MANAGEMENT INC/NY3.31%
VANGUARD PORTFOLIO MANAGEMENT LLC2.65%

Funds

Fund% owned
Income Fund of America103.13%
Bond Fund of America57.02%
American Funds Multi-Sector Income Fund55.61%
The Osterweis Strategic Income Fund51.56%
American High Income Trust38.54%
American Funds Strategic Bond Fund22.64%
Capital Income Builder17.51%
JPMorgan Income Fund15.56%
JPMorgan High Yield Fund14.17%
iShares Broad USD High Yield Corporate Bond ETF9.82%

OakChart. ACH. Cached 15 minutes. Terms